NEW YORK (GenomeWeb) – Caribou Biosciences, a CRISPR platform technology firm, has completed a $30 million Series B financing round.

New investors Anterra Capital, Heritage Group, Maverick Capital Ventures, and Pontifax AgTech joined existing investors in the round, including F-Prime Capital Partners, Novartis, Mission Bay Capital, and 5 Prime Ventures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.